期刊文献+

常规肺功能检查与运动心肺功能检查在预测高危胸部肿瘤患者术后心肺并发症中的作用 被引量:6

Role of conventional pulmonary function tests and cardiopulmonary exercise test in the prediction of postoperative cardiopulmonary compfications in high risk thoracic cancer patients
原文传递
导出
摘要 目的比较常规肺功能与运动心肺功能检查在预测高危胸部肿瘤患者不同术式治疗后心肺并发症方面的价值。方法2006年1月至2009年1月间连续收治的216例胸部肿瘤患者中接受手术治疗的患者159例,收集其常规肺通气功能检查、运动心肺功能检查及临床资料,回顾性分析常规肺通气功能检查、运动心肺功能检查指标与术后心肺并发症的关系。结果159例手术治疗的患者中,有36例(22.6%)患者术后发生心肺并发症共44例次,10例(6.3%)患者发生手术相关并发症,3例(1.9%)患者围手术期死亡。将159例手术治疗的患者,分别根据V02max/pred的检测值分为≥65.0%组和〈65.0%组,根据V0.max·kg^-1·min。的检测值分为≥20.0ml组、15.0~19.9ml组和〈15.0ml组,根据FEVl的检测值分为≥2.00L组、1.20—1.99L组和〈1.20L组,心肺并发症发生率在V0,max/pred〈65.0%组、V02max·kg^-1·min。〈15.0ml组和FEV1〈1.2L组略有升高,但各组间差异多无统计学意义。多因素Logistic回归分析显示,患者的伴随疾病(OR=1.824,P=0.028)、综合肺通气功能状况(OR=1.832,P=0.008)、手术方式(OR=2.227,P=0.026)、手术相关并发症(OR=42.574,P:0.001)是术后心肺并发症发生的独立影响因素,患者综合肺通气功能状况(OR=2.565,P:0.047)、V0,max/pred(OR=0.020,P=0.004)、V0,max·kg^-1·min^-1(OR=8.809,P=0.013)和手术相关并发症(OR=107.517,P〈0.001)是术后呼吸功能衰竭发生的独立影响因素。结论常规肺功能中的FEVl、运动心肺功能中的V。max/wed和V02nlax·kg^-1·min^-1指标可将患者的心肺功能状况分层,但以V0,max·kg^-1·min^-1为最优,且与FEVl相关性较好。V02.max·kg^-1·min^-1与术后心肺并发症发生有关。 Objective To evaluate and compare the value of cardiopulmonary exercise test and conventional pulmonary funetion tests in the prediction of postoperative cardiopulmonary complications in high risk patients with chest malignant tumors. Methods From January 2006 to January 2009, 216 consecutive patients with thoraeic malignant tumors underwent conventional pulmonary function tests (PFT, spirometry + DLCOsb for diffusion capacity) and cardiopulmonary exercise test (CPET) preoperatively. The correlation of postoperative cardiopulmonary complications with the parameters of PFT and CPET were retrospectively analyzed using Chi-square test, independent sample t-test and logistic regression analysis. The P value 〈 0.05 was considered as statistically significant. Results Of the 216 patients, 57 did not receive operation due to advanced stage diseases or poor cardiopulmonary funetion in most of them. The remaining 159 underwent different modes of operations. Thirty-six patients (22.6%) in this operated group had postoperative cardiopulmonary complications and 10 patients (6. 3% ) developed operation-related complications. Three patients ( 1.9% ) died of the complications within 30 days postoperatively. The patients were stratified into groups based on Vo2max/pred ( ≥65.0%, 〈65.0% ) ; Vo2max ·kg^-1·min^-1 (≥20 m1,15-19.9 ml, 〈15 ml) and FEV1 ( ≥2.0 L, 1.2-1.99 L, 〈1.2 L) according to the criteria in reported papers. There was statistically significant difference among these groups in the parameters (P 〈 0.05 ) , the rates of postoperative cardiopulmonary complications were much higher in the groups with poor cardiopulmonary function ( Vo2max/pred 〈65.0% ; Vo2max ·kg^-1·min^-1 〈 15 ml or FEV1 〈 1.2 L). It was shown by logistic regression analysis that postoperative cardiopulmonary complications were significantly correlated with age, associated diseases, poor results of PFT or CPET, operation modes and operation-related complications. Conclusions FEV1 in spirometry, Vo2 max·kg^-1·min-1 and Vo2 max/pred in cardiopulmonary exercise test can be used to stratify the patients' cardiopulmonary function status and is correlated well with FEV1. Vo2 max·kg^-1·min is the best parameter among these three parameters to predict the risk of postoperative cardiopulmonary complications in patients with chest malignant tumors and borderline cardiopulmonary function.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第1期51-56,共6页 Chinese Journal of Oncology
关键词 胸部肿瘤 呼吸功能检查 心肺运动试验 手术后并发症 Thoracic neoplasms Reapiratory function tests Cardiopulmonary exercise tests Postoperative complications
  • 相关文献

参考文献15

  • 1Takamori S, Rikimaru T, Hayashi A, et al. A preoperative alternating chemotherapy and radiotherapy program for patients with stage ⅢA (N2) non-small cell lung cancer. Lung Cancer, 2000, 29:49-56.
  • 2Depierre A, Milleron B, Moro-Siblot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage Ⅰ (except T1N0) , Ⅱ, and Ⅲa non-small-cell lung cancer. J Clin Oncol, 2002, 20:247-253.
  • 3Gopal R, Starkschall G, Tucker SL, et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2003, 56:114-120.
  • 4Miller KL, Zhou SM, Barrier RC Jr, et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys, 2003, 56:611-615.
  • 5Nagamatsu Y, Maeshiro K, Kimura NY, et al. Long-term recovery of exercise capacity and pulmonary function after lobectomy. J Thorac Cardiovasc Surg, 2007, 134 : 1273-1278.
  • 6Win T, Jackson A, Sharples L, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest, 2005, 127:1159- 1165.
  • 7Villani F, Busia A. Preoperative evaluation of patients submitted to pneumonectomy for lung carcinoma: role of exercise testing. Tumori, 2004, 90:405409.
  • 8Loewen GM, Watson D, Kohman L, et al. Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol, 2007, 2 : 6194525.
  • 9李琦,操敏,阮红云,张国红,孙桂新,东博涛,王志茹.心肺运动试验评估肺功能减退的肺癌患者手术适应证探讨[J].中国胸心血管外科临床杂志,2004,11(3):192-195. 被引量:7
  • 10Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest, 2007, 132(3 Suppl) :161S-177S.

二级参考文献4

  • 1British Thoracic Society ; Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines :guidelines on the selection of patients with lung cancer for surgery. Thorax, 2001,56(2):89-108.
  • 2American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2003, 167(2):211-277.
  • 3Powell CA, Caplan CE. Pulmonary function tests in preoperative pulmonary evaluation. Clin Chest Med, 2001, 22(4): 703-714.
  • 4李宝兰,李琦,许绍发,张国红,东博涛.肺癌患者围术期换气功能的研究[J].中华结核和呼吸杂志,1998,21(12):735-738. 被引量:6

共引文献6

同被引文献35

  • 1蒋治勤,蒋国梁,施达仁,张容轩,傅小龙,钱浩.Ⅰ期非小细胞肺癌预后因素的研究[J].中华肿瘤杂志,2004,26(6):364-368. 被引量:6
  • 2杜峻,何华英,王玫,袁静,刘运娣,龚晓玲.老年慢性支气管炎病人使用振动排痰机的护理体会[J].中华护理杂志,2005,40(1):62-62. 被引量:41
  • 3Lanuti M,Sharma A,Digamarthy SR,et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer[J].J Thorac Cardiovasc Surg,2009,137 ( 1 ) : 160-166o.
  • 4Nici L,Donner C,Wonters E,et al.American thoracic society/european respiratory society statement on pulmonary rehabilitation[J].Am J Respir Crit Care Med,2006,173(12) : 1390-1413.
  • 5Ceppa DP,Kosinski AS,Berry MF,et al. Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function:A society of thoracic surgeons database analysis[J].Annals of surgery,2012,256(3):487-493.
  • 6Miled-Marret EF,Bazelly B,et al.The Risk and protective the factors for major complications after pneumonectomy forLung cancer[J].Journal of Interact Cardio Vasc Thorac Surg,2010,10(6):936-939.
  • 7Shirinzadeh A,Talebi Y.Pulmonary complications due to esophagectomy[J].J Cardiovasc Thorac Res,2011,3(3):93-96.
  • 8Smetana GW.Postoperative pulmonary complications:an update on risk assessment and reduction[J].Journal of Cleve Clin J Med,2009,76(4):S60-65.
  • 9Paleari D,Rossi GA,Nicolini G,et al.Ambroxol:a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood[J].Expert Opin Drug Discov,2011,6(11):1203-1214.
  • 10MAO You-sheng HE Jie YAN Shao-ping Dong Jing-si CHENG Gui-yu SUN Ke-lin LIU Xiang-yang FANG De-kang LI Jian WANG Yong-gang HUANG Jin-feng.Cardiopulmonary exercise testing in the evaluation of high risk patients with lung cancer[J].Chinese Medical Journal,2010(21):3089-3094. 被引量:7

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部